Pharmaceuticals, Biotechnology and Life Sciences
MALVERN, Pa., March 07, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”) (NASDAQ: TELA), a commercial-stage medical technology company focused…
Lancement de l’étude clinique de Phase III NATiV3 avec lanifibranor dans la NASH Réception d’un paiement d’étape de 4 millions…
Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolization Villepinte, France, March 7th, 2022 – Guerbet (FR0000032526…
Published data demonstrate potent, durable, and specific editing and potential for therapeutic applications in liver using a subcutaneous GalNAc-conjugated oligonucleotide…
EMERYVILLE, Calif., March 06, 2022 (GLOBE NEWSWIRE) — Biotechnology company Zymergen (ZY) is pleased to announce early results from its…
Encouraging preliminary results from BALLI-01 study (evaluating UCART22) in relapsed/refractory B-cell Acute Lymphoblastic Leukemia presented at ASH 2021 annual meeting; BALLI-01…
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present…
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PTBURLINGAME, Calif., March 03, 2022 (GLOBE…
MISSISSAUGA, Ontario, March 03, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its…
WALTHAM, Mass., March 03, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for…